Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 2/20 | 0.34 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
| ▸ | PARL | Q9H300 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14898349 | 0.88 | MGLL (0.31) | MGLL | |
| SCHEMBL13447721 | 0.86 | MGLL (0.33) | MGLLGLAPARL | |
| SCHEMBL12285677 | 0.84 | POLB (0.31) | POLBGAANPSR1 | |
| SCHEMBL17777287 | 0.83 | MGLL (0.33) | MGLLGLA | |
| SCHEMBL2570463 | 0.83 | MGLL (0.33) | MGLLGLA | |
| SCHEMBL6699078 | 0.83 | MGLL (0.33) | MGLLGLAPOLBGAANPSR1 | |
| SCHEMBL7924643 | 0.82 | MGLL (0.32) | MGLLGLA | |
| SCHEMBL12045573 | 0.80 | POLB (0.37) | POLBGAANPSR1 | |
| SCHEMBL23619542 | 0.80 | MGLL (0.34) | MGLLKMT2AATM | |
| SCHEMBL17664956 | 0.80 | MGLL (0.31) | MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11708446-B2 | Polymers and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-07-25 | — | — | US | claimed |
| CN-111072877-B | Method for self-assembling protein conjugate into nano-microsphere by polymerization initiation | 南京理工大学 | 2022-03-22 | — | — | CN | claimed |
| US-20210221937-A1 | POLYMERS AND USES THEREOF | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-07-22 | — | — | US | claimed |
| US-11041026-B2 | Reactions enabled by thermoresponsive and photoresponsive gels | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2021-06-22 | — | — | US | claimed |
| CN-112618803-A | Preparation method of temperature response type bionic nanocone dual-functional antibacterial surface | 大连理工大学 | 2021-04-09 | — | — | CN | claimed |
| CN-108976362-B | Method for non-genetic modification of microorganisms based on phase transition lysozyme nano-film | 陕西师范大学 | 2020-11-17 | — | — | CN | claimed |
| CN-111072877-A | Method for self-assembling protein conjugate into nano-microsphere by polymerization initiation | 南京理工大学 | 2020-04-28 | — | — | CN | claimed |
| WO-2018140977-A1 | REACTIONS ENABLED BY THERMORESPONSIVE AND PHOTORESPONSIVE GELS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2018-08-02 | — | — | WO | claimed |
| US-20120016082-A1 | CONJUGATION REACTIONS | BIOCOMPATIBLES UK LIMITED (GB) | 2012-01-19 | — | — | US | claimed |
| EP-1592719-B1 | CONJUGATION REACTIONS | BIOCOMPATIBLES UK LTD (GB) | 2008-03-26 | — | — | EP | claimed |
| US-20060135714-A1 | Conjugation reactions | BIOCOMPATIBLES UK LIMITED (GB) | 2006-06-22 | — | — | US | claimed |
| EP-1592719-A1 | CONJUGATION REACTIONS | Biocompatibles UK Limited (GB) | 2005-11-09 | — | — | EP | claimed |
| WO-2004063237-A1 | CONJUGATION REACTIONS | BIOCOMPATIBLES UK LIMITED (GB) | 2004-07-29 | — | — | WO | claimed |
| US-20260007755-A1 | SELF-ASSEMBLED DIBLOCK COPOLYMERS COMPOSED OF PEGMEMA AND DRUG BEARING POLYMERIC SEGMENTS | RS ARASTIRMA EGITIM DANISMANLIK ILAC SANAYI TICARET ANONIM SIRKETI (TR) | 2026-01-08 | — | — | US | disclosed |
| US-12427199-B2 | Self-assembled diblock copolymers composed of pegmema and drug bearing polymeric segments | RS ARASTIRMA EGITIM DANISMANLIK ILAC SANAYI TICARET ANONIM SIRKETI (TR) | 2025-09-30 | — | — | US | disclosed |
| EP-3935149-B1 | METHOD FOR SEPARATING CELLS USING A TEMPERATURE-RESPONSIVE POLYMER | UNIV SIEGEN (DE) | 2025-04-23 | — | — | EP | disclosed |
| US-20080300348-A1 | Polymer | WARWICK EFFECT POLYMERS LIMITED | 2008-12-04 | — | — | US | disclosed |
| WO-2007100902-A2 | ACRYLOYLOXYETHYLPHOSPHORYLCHOLINE CONTAINING POLYMER CONJUGATES AND THEIR PREPARATION | OLIGASIS CORPORATION (US) | 2007-09-07 | — | — | WO | disclosed |
| EP-1646661-A2 | LIVING RADICAL POLYMERIZATION INITIATOR COMPRISING A FUNCTIONAL GROUP CAPABLE OF REACTING WITH POLYPEPTIDES OR THE LIKE, COMB POLYMER OBTAINED THEREWITH, POLYPEPTIDE CONJUGATES AND DRUNG OBTAINED THEREFROM | Warwick Effect Polymers Limited (GB) | 2006-04-19 | — | — | EP | disclosed |
| WO-2004113394-A2 | LIVING RADICAL POLYMERIZATION INITIATOR COMPRISING A FUNCTIONAL GROUP CAPABLE OF REACTING WITH POLYPEPTIDES OR THE LIKE, COMB POLYMER OBTAINED THEREWITH, POLYPEPTIDE CONJUGATES AND DRUGS OBTAINED THEREFROM | WARWICK EFFECT POLYMERS LIMITED (GB) | 2004-12-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260007755-A1 | SELF-ASSEMBLED DIBLOCK COPOLYMERS COMPOSED OF PEGMEMA AND DRUG BEARING POLYMERIC SEGMENTS | CLTB, F13B, FGB | MGLL 3400/4885GLA 703/4885PARL 2264/4885 |
| US-20120016082-A1 | CONJUGATION REACTIONS | PHPT1, GNE, MGMT | MGLL 4388/4885GLA 3819/4885PARL 3968/4885 |
| US-12427199-B2 | Self-assembled diblock copolymers composed of pegmema and drug bearing polymeric segments | BCR, EGFR, PBRM1 | MGLL 3293/4885GLA 2674/4885PARL 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.